文献速递物质与行为成瘾心境障碍

阿片使用障碍与自杀未遂的跨表型关联:多基因关联与孟德尔随机化新证据

Cross-phenotype relationship between opioid use disorder and suicide attempts: new evidence from polygenic association and Mendelian randomization analyses.
PubMed 文献 · Mol Psychiatry · 2023-06-20

研究利用逾15万英国生物银行样本的表型与基因型及逾60万欧洲血统个体的全基因组关联汇总统计,评估阿片使用障碍(OUD)与自杀未遂(SA)的关联与双向关系。结果显示两者在表型与遗传水平均强关联,多基因易感性双向预测对方风险,但控制精神疾病共病后多基因关联明显减弱;孟德尔随机化提示SA遗传易感性对OUD风险可能存在因果关联。

要点

  • OUD与SA在表型(总体OR=2.94)和遗传水平(rg=0.38–0.5)均强关联。
  • 多基因易感性双向预测OUD与SA风险,但控制精神疾病共病后明显减弱。
  • 孟德尔随机化提示SA遗传易感性可能因果性增加OUD风险。

核心结论

  • OUD与SA存在表型与遗传水平的强关联,并提示SA遗传易感性对OUD风险可能存在因果关联。

研究设计与样本

  • 利用逾15万英国生物银行样本的原始表型与基因型,以及逾60万欧洲血统个体的全基因组关联汇总统计。
  • 采用流行病学关联、遗传相关、多基因风险评分预测与孟德尔随机化等多种统计与遗传学工具分析。

主要发现

  • 表型水平OUD与SA强关联:总体样本OR=2.94(P=1.59×10-14),非精神疾病亚组OR=2.15(P=1.07×10-3)。
  • 遗传相关rg=0.38(条件化精神疾病特征)与0.5(未条件化)。
  • SA多基因易感性升高与OUD风险升高相关(OR=1.08,FDR=1.71×10-3);OUD多基因易感性与SA风险相关(OR=1.09,FDR=1.73×10-6)。
  • 控制共病精神疾病后,上述多基因关联明显减弱。
  • 两样本单变量孟德尔随机化OR=1.14(P=0.001),多变量孟德尔随机化OR=1.08(P=0.001),提示SA遗传易感性至OUD风险的可能因果关联。

临床怎么用

  • 针对OUD或SA任一表型的预防策略,应考虑对另一表型进行筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical epidemiological studies have found high co-occurrence between suicide attempts (SA) and opioid use disorder (OUD). However, the patterns of correlation and causation between them are still not clear due to psychiatric confounding. To investigate their cross-phenotype relationship, we utilized raw phenotypes and genotypes from >150,000 UK Biobank samples, and genome-wide association summary statistics from >600,000 individuals with European ancestry. Pairwise association and a potential bidirectional relationship between OUD and SA were evaluated with and without controlling for major psychiatric disease status (e.g., schizophrenia, major depressive disorder, and alcohol use disorder). Multiple statistical and genetics tools were used to perform epidemiological association, genetic correlation, polygenic risk score prediction, and Mendelian randomizations (MR) analyses. Strong associations between OUD and SA were observed at both the phenotypic level (overall samples [OR = 2.94, P = 1.59 ×10-14]; non-psychiatric subgroup [OR = 2.15, P = 1.07 ×10-3]) and the genetic level (genetic correlation rg = 0.38 and 0.5 with or without conditioning on psychiatric traits, respectively). Consistently, increasing polygenic susceptibility to SA is associated with increasing risk of OUD (OR = 1.08, false discovery rate [FDR] =1.71 ×10-3), and similarly, increasing polygenic susceptibility to OUD is associated with increasing risk of SA (OR = 1.09, FDR = 1.73 ×10-6). However, these polygenic associations were much attenuated after controlling for comorbid psychiatric diseases. A combination of MR analyses suggested a possible causal association from genetic liability for SA to OUD risk (2-sample univariable MR: OR = 1.14, P = 0.001; multivariable MR: OR = 1.08, P = 0.001). This study provided new genetic evidence to explain the observed OUD-SA comorbidity. Future prevention strategies for each phenotype needs to take into consideration of screening for the other one.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Huang Y, Chen D, Levin AM, et al. Cross-phenotype relationship between opioid use disorder and suicide attempts: new evidence from polygenic association and Mendelian randomization analyses. Mol Psychiatry. 2023. PMID: 37340172. doi:10.1038/s41380-023-02124-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。